Sponsor study identifier
interventional
370
2 countries
2
Study Start
March 2009
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
April 2011
Actual (reported)Study Completion
April 2011
Actual (reported)Non-randomized, comparative study (1:1 allocation) to study interactions between nevirapine-containing antiretroviral therapies and combined oral contraceptive pills.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 2011
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 16, 2009
Actual (reported)January 26, 2009
Actual (reported)March 2009
Date type not reportedThis date has not been verified as actual or estimated.
April 2011
Actual (reported)April 2011
Actual (reported)Ovulation as determined by weekly blood progesterone (P) measurement
2 months
Pregnancy as detected by monthly urine pregnancy testing
6 months
Adverse events (AE) recording
6 months
ART/COC group
COC group
30 MCG OF ETHINYL ESTRADIOL AND 150 MCG LEVOGESTREL
30 MCG OF ETHINYL ESTRADIOL AND 150 MCG LEVOGESTREL
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
, RHRU National Office, University of Witwatersand
Esselent Saint Hillbrow, Johannesburg, 2001, South Africa
Makerere University Medical School, Mulago Hospital, Department of Obstetrics and Gynecology
Kampala, Kampala, Uganda
Nanda K, Delany-Moretlwe S, Dube K, Lendvay A, Kwok C, Molife L, Nakubulwa S, Edward VA, Mpairwe B, Mirembe FM. Nevirapine-based antiretroviral therapy does not reduce oral contraceptive effectiveness. AIDS. 2013 Oct;27 Suppl 1:S17-25. doi: 10.1097/QAD.0000000000000050.
Kavita Nanda, MD
FHI 360
Vera Halpern, MD
FHI 360
First Submitted
January 16, 2009
First Posted
January 26, 2009
Study Start
March 2009
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
April 2011
Actual (reported)Raltegravir vs. Atazanavir in Combination With Truvada® for the Treatment of Antiretroviral naïve HIV Infected Patients
Contact the study team to confirm eligibility.
Study Completion
April 2011
Actual (reported)Last Updated
October 31, 2011
Record last verified: 2011-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: